As we pursue our mission to serve patients and families affected by rare diseases, Alexion is committed to building strong and sustainable business partnerships that enable us to develop and deliver life-changing therapies. As a fully-integrated biopharmaceutical company, we bring world-class expertise and resources to our collaborations, including proven global capabilities spanning scientific, medical, regulatory, manufacturing and commercial operations.

Business Development

Expanding our pipeline through business development is a key component of Alexion’s strategic focus. As part of this effort, we aim to build a robust clinical-stage pipeline through licensing, acquiring, or partnering on clinical-stage assets.

Our business development team is currently evaluating opportunities with an exclusive focus on developing life-changing therapies for patients with rare diseases that lack effective treatment options in our core areas of focus:

  • Hematology and nephrology
  • Neurology
  • Metabolics
  • FcRn

We are also seeking partnerships that will maximize the potential of our internal complement research efforts through select opportunities in complement.


Alexion offers unique capabilities and expertise that make us the partner of choice in developing promising drug candidates into leading rare disease therapies, including:

  • Global leadership in complement biology with 20+ years of experience and a dedicated world-class research team
  • Proven track record in orphan drug development, clinical trial design and recruitment, regulatory affairs, and manufacturing
  • Deep understanding of the patient journey to implement transformative therapies
  • Access and commercial infrastructure to enable us to serve patients in 50 countries

Our BD team closely manages each partner relationship to ensure open and ongoing communication and mutual decision-making.

Building Our Team

Led by Aradhana Sarin, M.D., EVP, Chief Strategy and Business Officer, we are building a best-in-class team to expand our partnership network and identify external candidates that have the potential to become leading therapies that transform patients’ lives. We’re currently looking for experts in the following areas to join our team:

  • Strategic evaluation
  • Business analysis
  • Transactions
View our open positions


Investigator-Sponsored Research (ISR)

Alexion is committed to supporting investigator-sponsored research (ISR) to advance medical and scientific knowledge about our products, product candidates, and therapeutic areas of interest.

Learn more

Discovery Partnerships

Alexion supports academic investigators as they advance their research and develop innovative, life-changing therapies through our collaborative Discovery Partnerships program.

Learn more